150 related articles for article (PubMed ID: 37024258)
1. Efficacy and safety of novel oral anticoagulants for the treatment of cancer-associated venous thromboembolism: protocol for an umbrella review of systematic reviews and meta-analyses.
Xia Y; Tang L; Hu Y
BMJ Open; 2023 Apr; 13(4):e066853. PubMed ID: 37024258
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Oral anticoagulants for primary prevention, treatment and secondary prevention of venous thromboembolic disease, and for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis and cost-effectiveness analysis.
Sterne JA; Bodalia PN; Bryden PA; Davies PA; López-López JA; Okoli GN; Thom HH; Caldwell DM; Dias S; Eaton D; Higgins JP; Hollingworth W; Salisbury C; Savović J; Sofat R; Stephens-Boal A; Welton NJ; Hingorani AD
Health Technol Assess; 2017 Mar; 21(9):1-386. PubMed ID: 28279251
[TBL] [Abstract][Full Text] [Related]
4. Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation.
Kahale LA; Matar CF; Tsolakian I; Hakoum MB; Barba M; Yosuico VE; Terrenato I; Sperati F; Schünemann H; Akl EA
Cochrane Database Syst Rev; 2021 Oct; 10(10):CD006466. PubMed ID: 34622445
[TBL] [Abstract][Full Text] [Related]
5. Prophylaxis of thromboembolism during therapy with asparaginase in adults with acute lymphoblastic leukaemia.
Rank CU; Lynggaard LS; Als-Nielsen B; Stock W; Toft N; Nielsen OJ; Frandsen TL; Tuckuviene R; Schmiegelow K
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD013399. PubMed ID: 33038027
[TBL] [Abstract][Full Text] [Related]
6. Risk of Substantial Intraocular Bleeding With Novel Oral Anticoagulants: Systematic Review and Meta-analysis.
Caldeira D; Canastro M; Barra M; Ferreira A; Costa J; Pinto FJ; Ferreira JJ
JAMA Ophthalmol; 2015 Jul; 133(7):834-9. PubMed ID: 25950647
[TBL] [Abstract][Full Text] [Related]
7. Prediction models for venous thromboembolism in ambulatory adults with pancreatic and gastro-oesophageal cancer: protocol for systematic review and meta-analysis.
Zaheer A; Naumovski N; Toohey K; Niyonsenga T; Yip D; Brown N; Mortazavi R
BMJ Open; 2022 Mar; 12(3):e056431. PubMed ID: 35246422
[TBL] [Abstract][Full Text] [Related]
8. Use of heparins in patients with cancer: individual participant data meta-analysis of randomised trials study protocol.
Schünemann HJ; Ventresca M; Crowther M; Briel M; Zhou Q; Garcia D; Lyman G; Noble S; Macbeth F; Griffiths G; DiNisio M; Iorio A; Beyene J; Mbuagbaw L; Neumann I; Van Es N; Brouwers M; Brozek J; Guyatt G; Levine M; Moll S; Santesso N; Streiff M; Baldeh T; Florez I; Gurunlu Alma O; Solh Z; Ageno W; Marcucci M; Bozas G; Zulian G; Maraveyas A; Lebeau B; Buller H; Evans J; McBane R; Bleker S; Pelzer U; Akl EA;
BMJ Open; 2016 Apr; 6(4):e010569. PubMed ID: 27130164
[TBL] [Abstract][Full Text] [Related]
9. Non-pharmacological treatments for irritable bowel syndrome: study protocol of an umbrella review of systematic review and meta-analyses.
Jin S; Li YF; Qin D; Luo DQ; Guo H; Gao XH; Yue L; Zheng H
BMJ Open; 2019 Mar; 9(3):e027778. PubMed ID: 30898835
[TBL] [Abstract][Full Text] [Related]
10. Wound complications and bleeding with new oral anticoagulants in patients undergoing total joint arthroplasty: A systematic review and meta-analysis of randomized controlled trials.
Wang M; Xie J; Zheng H; Wang S; Zhou R; Li W; Xue E; Wang X; Jiang J; Wu T; Zhan S
Br J Clin Pharmacol; 2022 Feb; 88(2):500-513. PubMed ID: 34322914
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of levetiracetam in children with epilepsy: protocol for an umbrella review of systematic reviews and meta-analyses of randomised controlled trials.
Gan J; Ma D; Xiong T
BMJ Open; 2019 Jul; 9(7):e029811. PubMed ID: 31296513
[TBL] [Abstract][Full Text] [Related]
12. Management of haemorrhoids: protocol of an umbrella review of systematic reviews and meta-analyses.
Chen M; Tang TC; He TH; Du YJ; Qin D; Zheng H
BMJ Open; 2020 Mar; 10(3):e035287. PubMed ID: 32213524
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of new oral anticoagulants for extended treatment of venous thromboembolism: systematic review and meta-analyses of randomized controlled trials.
Sardar P; Chatterjee S; Mukherjee D
Drugs; 2013 Jul; 73(11):1171-82. PubMed ID: 23812923
[TBL] [Abstract][Full Text] [Related]
14. Risk of venous thromboembolism in patients undergoing gastric cancer surgery: protocol for a systematic review and meta-analysis.
Wang D; Yu Y; Tao P; Wang D; Chen Y; Chen H
BMJ Open; 2020 Jan; 10(1):e033267. PubMed ID: 31919125
[TBL] [Abstract][Full Text] [Related]
15. Long-term risk of recurrence after discontinuing anticoagulants for a first unprovoked venous thromboembolism: protocol for a systematic review and meta-analysis.
Khan F; Rahman A; Carrier M; Kearon C; Schulman S; Couturaud F; Prandoni P; Eichinger S; Becattini C; Agnelli G; Büller HR; Brighton TA; Palareti G; Pinede L; Sabri E; Hutton B; Wells GA; Rodger MA;
BMJ Open; 2017 Sep; 7(9):16950. PubMed ID: 28939565
[TBL] [Abstract][Full Text] [Related]
16. The management of anticoagulants in patients with atrial fibrillation and history of falls or risk of falls: protocol for a systematic review and meta-analysis.
Galvain T; Hill R; Donegan S; Lisboa P; Lip GYH; Czanner G
Syst Rev; 2022 Apr; 11(1):63. PubMed ID: 35395931
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation and Venous Thromboembolism: A Systematic Review and Meta-analyses.
Almutairi AR; Zhou L; Gellad WF; Lee JK; Slack MK; Martin JR; Lo-Ciganic WH
Clin Ther; 2017 Jul; 39(7):1456-1478.e36. PubMed ID: 28668628
[TBL] [Abstract][Full Text] [Related]
18. Models for predicting venous thromboembolism in ambulatory patients with lung cancer: a systematic review protocol.
Yan AR; Samarawickrema I; Naunton M; Peterson GM; Yip D; Mortazavi R
BMJ Open; 2021 Dec; 11(12):e055322. PubMed ID: 34853112
[TBL] [Abstract][Full Text] [Related]
19. Net clinical benefit analysis of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and chronic kidney disease: Protocol for a systematic review and meta-analysis.
Shen NN; Zhang XM; Le KJ; Wei AH; Wu Y; Gu ZC
Medicine (Baltimore); 2019 Jun; 98(26):e16194. PubMed ID: 31261559
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of nonvitamin K antagonist oral anticoagulants during catheter ablation of atrial fibrillation: A systematic review and meta-analysis.
Ge Z; Faggioni M; Baber U; Sartori S; Sorrentino S; Farhan S; Chandrasekhar J; Vogel B; Qadeer A; Halperin J; Reddy V; Dukkipati S; Dangas G; Mehran R
Cardiovasc Ther; 2018 Oct; 36(5):e12457. PubMed ID: 29971964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
